In a parallel clinical cohort of 47,324 patients, GLP-1 receptor agonist use was associated with lower inflammatory biomarkers and fewer MACE events, with the benefits persisting in subgroups stratified by BMI or HbA1c
[DOI] [PubMed] [Google Scholar] 105.Halley MC, Petersen J, Nasrallah C, Szwerinski N, Romanelli R, Azar KMJ
the oral kind
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Additionally, the delayed gastric emptying caused by GLP-1 medications may affect the absorption of some oral medicines, so follow product-specific guidance and consult your healthcare provider about potential interactions
This patient-first approach minimizes side effects and maximizes results, ensuring your journey is as comfortable as it is effective